Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Epistem Holdings plc

Epistem is a biotechnology company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal and dermatological diseases. Epistem develops innovative therapeutics, biomarkers and diagnostics alongside providing contract research services to drug development companies. The Group's core expertise is focused on the regulation of adult stem cells located in epithelial tissue, which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. *

 

Period Start 2000-01-01 established_pre
  Group Epistem (Group)
Products Industry stem cell research
  Industry 2 BIOTECH
Persons Person Walls, Matthew (EpiStem 200704 CEO)
  Person 2 Rylands, John (Epistem 201312 Finance Director)
     
Region Region Manchester, Greater Manchester
  Country United Kingdom (GB)
  Street 48 Grafton Street
  City M13 9XX Manchester
  Tel +44-161-606-7258
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: OctoPlus N.V.. (5/20/11). "Press Release: Shareholders OctoPlus Appoint Jan Egberts to Executive Board". Leiden.
     
   
Record changed: 2017-04-01

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Epistem (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top